We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+14.96%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$627M
AUM Growth
+$181M
Cap. Flow
+$130M
Cap. Flow %
20.82%
Top 10 Hldgs %
46.99%
Holding
210
New
76
Increased
33
Reduced
30
Closed
60

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$17.7M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$9.51M
3
TWLO icon
Twilio
TWLO
+$7.81M
4
STKL
SunOpta
STKL
+$7.64M
5
LHCG
LHC Group LLC
LHCG
+$7.47M

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$10.6M
2
MED icon
Medifast
MED
+$9.84M
3
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
+$9M
4
FSLR icon
First Solar
FSLR
+$8.39M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$7.43M

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Healthcare 15.11%
3 Industrials 12.05%
4 Consumer Discretionary 6.3%
5 Consumer Staples 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FISV
126
Fiserv Inc
FISV
$28.8B
$231K 0.04%
+2,000
New +$221K
WORK
127
DELISTED
Slack Technologies, Inc.
WORK
$225K 0.04%
+10,000
New +$223K
ALDX icon
128
Aldeyra Therapeutics
ALDX
$96.5M
$216K 0.03%
37,100
-10,000
-21% -$57.8K
SAIL
129
CALL
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$212K 0.03%
+9,000
New +$197K
PRQR icon
130
ProQR Therapeutics
PRQR
$251M
$198K 0.03%
+20,000
New +$156K
BFYT
131
PUT
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$193K 0.03%
+10,000
New +$226K
TPIC
132
DELISTED
TPI Composites
TPIC
$185K 0.03%
10,000
-115,000
-92% -$2.11M
VATE icon
133
INNOVATE Corp
VATE
$111M
$163K 0.03%
7,500
+2,500
+50% +$55K
APHA
134
DELISTED
Aphria Inc. Common Shares
APHA
$156K 0.02%
+30,000
New +$147K
CSTM icon
135
Constellium
CSTM
$3.89B
$148K 0.02%
11,000
+1,000
+10% +$13.8K
APEN
136
DELISTED
Apollo Endosurgery, Inc.
APEN
$143K 0.02%
50,188
– –
AGRX
137
DELISTED
Agile Therapeutics
AGRX
$125K 0.02%
+25
New +$87.3K
AMD icon
138
PUT
Advanced Micro Devices
AMD
$791B
$115K 0.02%
2,500
-3,000
-55% -$110K
GNLN icon
139
Greenlane Holdings
GNLN
$1.12M
– –
0
– –
PROF
140
Profound Medical
PROF
$263M
$114K 0.02%
+10,000
New +$92.2K
ABEO icon
141
Abeona Therapeutics
ABEO
$369M
$98K 0.02%
1,200
– –
PR
142
Permian Resources
PR
$17.6B
$81K 0.01%
+17,500
New +$64K
VRML
143
DELISTED
Vermillion, Inc.
VRML
$71K 0.01%
+88,084
New +$58K
SEEL
144
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$67K 0.01%
13
– –
EGIO
145
DELISTED
Edgio, Inc. Common Stock
EGIO
$63K 0.01%
+388
New +$61.4K
GE icon
146
GE Aerospace
GE
$368B
$28K ﹤0.01%
502
+201
+67% +$10.4K
MU icon
147
CALL
Micron Technology
MU
$988B
$27K ﹤0.01%
+500
New +$23.9K
GRDX
148
GridAI Technologies Corp
GRDX
$21.4M
– –
0
– –
AMD icon
149
CALL
Advanced Micro Devices
AMD
$791B
$23K ﹤0.01%
+500
New +$18.4K
ATNM icon
150
Actinium Pharmaceuticals
ATNM
$26.3M
$16K ﹤0.01%
2,500
– –
4 5
6
7 8

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Ardsley Advisory Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Ardsley Advisory Partners held 210 positions worth $627M, up 41% from $446M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Ardsley Advisory Partners deployed $130M of net new capital in Q4 2019, opening 76 new positions and adding to 33 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 110,000 shares worth $10.5M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Walt Disney, an estimated $10.6M trimmed.

  • Ardsley Advisory Partners's largest Q4 2019 buy was State Street SPDR S&P Biotech ETF: 110,000 shares worth $10.5M.
  • Ardsley Advisory Partners added most to Guardant Health in Q4 2019, an estimated $17.7M increase.
  • Ardsley Advisory Partners's biggest Q4 2019 reduction was Walt Disney, cutting an estimated $10.6M.
  • Ardsley Advisory Partners fully exited Medifast in Q4 2019, selling an estimated $9.84M.
  • Ardsley Advisory Partners's ten largest holdings make up 47% of its $627M portfolio in Q4 2019.
  • Ardsley Advisory Partners opened 76 new positions and closed 60 in Q4 2019.
  • Ardsley Advisory Partners's portfolio value rose 41% quarter-over-quarter to $627M.

Based on Ardsley Advisory Partners's 13F filing for Q4 2019, filed 14 Feb 2020.